Evidence map›Paper›PMID 39071169›Full record

ArticlePCN reports : psychiatry and clinical neurosciences2024

Combination of taking neuropsychiatric medications and psychological distress in pregnant women, with behavioral problems in children at 2 years of age: The Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study.

Ippei Takahashi, Taku Obara, Saya Kikuchi, Natsuko Kobayashi, Ryo Obara, Aoi Noda, Minoru Ohsawa, Tomofumi Ishikawa, Nariyasu Mano, Hidekazu Nishigori and 7 more

Abstract read
In one paragraph

Article in PCN reports : psychiatry and clinical neurosciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ippei TakahashiDivision of Molecular Epidemiology, Graduate School of Medicine Tohoku University Sendai Japan.ORCID 0000-0003-4858-2209
Taku ObaraDivision of Molecular Epidemiology, Graduate School of Medicine Tohoku University Sendai Japan.ORCID 0000-0002-3674-1674
Saya KikuchiDepartment of Psychiatry Tohoku Graduate School of Medicine Sendai Japan.
Natsuko KobayashiDepartment of Psychiatry Tohoku Graduate School of Medicine Sendai Japan.
Ryo ObaraDivision of Molecular Epidemiology, Graduate School of Medicine Tohoku University Sendai Japan.
Aoi NodaDivision of Molecular Epidemiology, Graduate School of Medicine Tohoku University Sendai Japan.
Minoru OhsawaDepartment of Education and Support for Regional Medicine Tohoku University Hospital Sendai Japan.
Tomofumi IshikawaLaboratory of Clinical Pharmacy Tohoku University Graduate School of Pharmaceutical Sciences Sendai Japan.
Nariyasu ManoDepartment of Pharmaceutical Sciences Tohoku University Hospital Sendai Japan.
Hidekazu NishigoriDepartment of Development and Environmental Medicine Fukushima Medical University Graduate School of Medicine Fukushima Japan.
Fumihiko UenoDepartment of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization Tohoku University Sendai Japan.
Genki ShinodaDivision of Molecular Epidemiology, Graduate School of Medicine Tohoku University Sendai Japan.
Keiko MurakamiDepartment of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization Tohoku University Sendai Japan.
Masatsugu OruiDivision of Molecular Epidemiology, Graduate School of Medicine Tohoku University Sendai Japan.
Mami IshikuroDivision of Molecular Epidemiology, Graduate School of Medicine Tohoku University Sendai Japan.
Hiroaki TomitaDepartment of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization Tohoku University Sendai Japan.
Shinichi KuriyamaDivision of Molecular Epidemiology, Graduate School of Medicine Tohoku University Sendai Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: To examine the association of the combination of taking neuropsychiatric medications from the onset of pregnancy to mid-pregnancy and maternal psychological distress at mid-pregnancy, with children's behavioral problems. Methods: Neuropsychiatric medication use from the onset of pregnancy to mid-pregnancy was defined by the self-reported name of the neuropsychiatric medication in the questionnaire in early and mid-pregnancy. Maternal psychological distress was defined by the Kessler Psychological Distress Scale (K6) ≥13 on the questionnaire in mid-pregnancy. We classified the participants into four categories based on the combination of taking neuropsychiatric medications and psychological distress: "None," "Medications only," "K6 ≥ 13 only," and "Both." Children's behavioral problems were assessed using the Child Behavior Checklist for Ages 1½-5 (CBCL) at 2 years of age. The clinical ranges of the internalizing and externalizing scales of the CBCL were defined as behavioral problems. We conducted a multivariable logistic regression analysis to examine the associations between the four categories of maternal exposure and children's behavioral problems. Results: Compared with the "None" category ( Conclusion: The category of mothers taking neuropsychiatric medications and having no psychological distress during pregnancy was not associated with children's behavioral problems in the present population.

Indexed as

behavioral problemsbirth cohortepidemiologyneuropsychiatric medicationspsychological distress

Identifiers

PMID39071169
PMCPMC11272827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.